Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses » Dermatomycoses » Tinea
Diseases [C] » Infections [C01] » Skin Diseases, Infectious » Dermatomycoses » Tinea
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Infectious » Dermatomycoses » Tinea
Description
Fungal infection of keratinized tissues such as hair, skin and nails. The main causative fungi include MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON. MeSH
Hierarchy View
Subtype Terms (4)
Onychomycosis
39 drugs (19 approved, 20 experimental)
Tinea Capitis
10 drugs (9 approved, 1 experimental)
Tinea cruris
8 drugs (5 approved, 3 experimental)
Tinea Pedis
46 drugs (21 approved, 25 experimental)
Approved Indicated Drugs (7)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (5)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (19)
Organization Involved with Phase 2 Indications (14)
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
